跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
7-methylxanthine
首页
药物
7-methylxanthine
7-methylxanthine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Theophylline and 3-isobutyl-1 methylxanthine based N-7 substituted derivatives displaying inhibitory activities on PDE-5 phospodiesterase
US 7550468 B2
申请人: CHEN ING-JUN
优先权: 2005
US
2 件公开
Method of treating behavioral disorders
US 2006069107 A1
申请人: KYOWA HAKKO KOGYO KK
优先权: 2005
US
2 件公开
7-[4-(Benzhydrylpiperazinyl-1)butyl]-3-methylxanthine and its salts with organic or inorganic acids possessing antihistaminic and antiallergenic activity
US 8569489 B2
申请人: GLUSHKOV ROBERT G
优先权: 2007
US
2 件公开
Theophylline and 3-isobutyl-1-methylxanthine based N-7 substituted derivatives displaying inhibitory activities on type five phosphodiesterase
US 2002035117 A1
申请人: CHEN ING-JUN
优先权: 2000
US
Theophylline and 3-isobutyl-1-methylxanthine based N-7 substituted derivatives displaying inhibitory activies on PDE-5 phosphodiesterase
US 2003199693 A1
申请人: CHEN ING-JUN
优先权: 2003
US
Diaminopyrimidines as modulators for an EP2 receptor
EP 2014657 A1
申请人: BAYER SCHERING PHARMA AG
优先权: 2007
EP
Preparation method of 3-methyl-7-propylxanthine
CN 102718764 A
申请人: SHIJIAZHUANG PHARM GROUP OUYI
优先权: 2012
CN
Industrial preparation process of linagliptin
CN 104496989 A
申请人: SHOUGUANG FUKANG PHARMACEUTICAL CO LTD
优先权: 2014
CN
Industrial production method of linagliptin
CN 106008508 A
申请人: HEFEI YUANZHI PHARMACEUTICAL R & D CO LTD
优先权: 2016
CN
Industrial preparation method of linagliptin
CN 110684026 A
申请人: SHANGHAI HAINI PHARMACEUTICAL CO LTD YANGTZE RIVER PHARMACEUTICAL GROUP
优先权: 2019
CN
第 1 / 2 页
上一页
下一页
药物
反馈